AcuCort’s drug ISICORT® demonstrates a three-year shelf life
AcuCort AB (Spotlight Stock Market: ACUC) today announced that the company’s drug ISICORT® has demonstrated a three-year shelf life.ISICORT® is a thin, fast-dissolving and user-friendly oral film for the treatment of acute and severe allergic reactions, croup in children, chemotherapy-induced nausea and vomiting (CINV) as well as for the treatment of COVID-19 patients who need supplemental oxygen treatment. The fast-dissolving oral film contains the glucocorticoid dexamethasone which is a well-known, often used and well-documented anti-inflammatory substance. “I am very pleased that